DIMENSIONAL FUND ADVISORS LP

Position in FTRE — Fortrea Holdings Inc.

CIK 354204 AUSTIN, TX

Position in FTRE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$28,711,737

+$16,467,039 QoQ

Shares Held

1,650,100

+26.9% QoQ

Ownership

1.74%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#17

of 334 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 91% Shared 6% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. FTRE ranks #51 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,711,737	1,650,100	+26.9%	Shares	Sole	2026-08-11
2026-03-31	$12,244,698	1,299,862	+163.8%	Shares	Sole	2026-05-07
2025-12-31	$8,500,471	492,781	-16.7%	Shares	Sole	2026-02-12
2025-09-30	$4,981,406	591,616	-14.2%	Shares	Sole	2025-11-12
2025-06-30	$3,408,045	689,888	-20.2%	Shares	Sole	2025-08-12
2025-03-31	$6,527,176	864,527	-4.3%	Shares	Sole	2025-05-13
2024-12-31	$16,842,329	903,074	-1.5%	Shares	Sole	2025-02-13
2024-09-30	$18,338,920	916,946	-1.8%	Shares	Sole	2024-11-07
2024-06-30	$21,799,208	933,985	+4.8%	Shares	Sole	2024-08-09
2024-03-31	$35,757,070	890,809	-0.1%	Shares	Sole	2024-05-10
2023-12-31	$31,130,832	892,001	-30.5%	Shares	Sole	2024-02-07
2023-09-30	$36,717,906	1,284,292	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.